Galmed Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. FDX
6. IBM
7. NKE
8. MU
9. AWK
10. ACN

Go back to Galmed Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

Galmed Pharma (GLMD) Misses Q4 EPS by 5c

March 13, 2018 7:09 AM EDT

Galmed Pharma (NASDAQ: GLMD) reported Q4 EPS of ($0.27), $0.05 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $274 thousand versus the consensus estimate of $290 thousand.

For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.

... More